Cannabis-Derived Drug For MS Launched In The UK

A drug derived from cannabis was recently made available in the UK market for treating multiple sclerosis symptoms. The said drug, known as Sativex, is made from cannabis plants grown in secret locations in the UK. Made by GW Pharmaceuticals PLC, it is the first prescription drug made from cannabis that is set to be up for sale in markets all over the world. It may provide legal access to the beneficial effects of an otherwise considered as an illegal drug.

With the availability of the drug Sativex, people in the UK suffering from multiple sclerosis may now legally treat symptoms such as pain due to the disease by using a legally approved version of cannabis. Sativex was approved by the UK Medicines and Healthcare products Regulatory Agency as a treatment for spasticity for MS patients who are not benefiting from other types of treatment. The said drug has been in development for around 11 years.

The approval for Sativex was based on successful clinical trials. The said drug will be marketed in the UK by Germany’s Bayer AG. Sativex has been previously made available on a limited basis to MS patients in Canada and parts of the UK although it hasn’t yet been marketed.

Source: http://online.wsj.com/article/SB10001424052748704895204575320392868152692.html?mod=googlenews_wsj

 
You can leave a response, or trackback from your own site.